Perspective Therapeutics CATX
NYSE CATX
$2.73 -0.02 (-0.73%)
As of: Oct 1, 2026 · 3:59 PM EDT

Perspective Therapeutics (CATX) Cash from Financing Activities (2010 - 2026)

Updated

Perspective Therapeutics' Cash from Financing Activities was $147,000 in Q2 2026, up 11.4% from $132,000 a year earlier but down 99.9% from the prior quarter.

Analysis

Perspective Therapeutics (CATX) Cash from Financing Activities (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Perspective Therapeutics' Cash from Financing Activities was $164.71 million through Jun 30, 2026; for FY2025, it was $10.31 million, down 96.4% from FY2024.

  • Cash from Financing Activities shows a five-year compound annual growth rate of 59.6% (FY2020 to FY2025).
  • In earlier years, Cash from Financing Activities was $289.39 million in FY2024, $785,000 in FY2023, $28,000 in FY2022 and $64.68 million in FY2021.
  • Quarterly Cash from Financing Activities has moved between -$80,000 (Q1 2023) and $166.33 million (Q1 2024) over five years.
  • Compared with a year earlier, Cash from Financing Activities was higher in 1 of the last five quarters, with an average decline of 50.1%.
  • Per Business Quant data, CATX's Cash from Financing Activities in the three quarters before Q2 2026 was $164.36 million (Q1 2026), -$13,000 (Q4 2025) and $213,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Perspective Therapeutics 312.60 Mn 312.60 Mn - 147,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 147,000.00
Mar 31, 2026 164.36 Mn
Dec 31, 2025 -13,000.00
Sep 30, 2025 213,000.00
Jun 30, 2025 132,000.00
Mar 31, 2025 9.97 Mn
Dec 31, 2024 345,000.00
Sep 30, 2024 628,000.00
Jun 30, 2024 122.08 Mn
Mar 31, 2024 166.33 Mn
Dec 31, 2023 352,000.00
Sep 30, 2023 1,000.00
Jun 30, 2023 512,000.00
Mar 31, 2023 -80,000.00
Dec 31, 2022 -28,000.00
Sep 30, 2022 28,000.00
Dec 31, 2021 56,000.00
Jun 30, 2021 243,000.00
Mar 31, 2021 55.98 Mn
Jun 30, 2020 874,000.00
API Access

Perspective Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=CATX&period=max&api_key=YOUR_API_KEY